See more : Diversified Energy Company PLC (DEC.L) Income Statement Analysis – Financial Results
Complete financial analysis of McKesson Corporation (MCK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- SBI Life Insurance Company Limited (SBILIFE.BO) Income Statement Analysis – Financial Results
- Imvest S.p.A. (YIV.MI) Income Statement Analysis – Financial Results
- Tronox Holdings plc (TROX) Income Statement Analysis – Financial Results
- Nippon Paper Industries Co., Ltd. (3863.T) Income Statement Analysis – Financial Results
- CSPC Pharmaceutical Group Limited (1093.HK) Income Statement Analysis – Financial Results
McKesson Corporation (MCK)
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.05B | 137.61B | 122.46B | 122.73B | 112.08B | 108.70B | 106.63B | 101.70B | 92.98B | 88.05B | 80.51B | 69.51B | 57.12B | 50.01B | 42.01B | 36.73B | 30.38B | 20.86B | 12.89B | 13.72B | 13.19B |
| Cost of Revenue | 296.37B | 264.35B | 250.84B | 226.08B | 219.03B | 202.57B | 197.17B | 187.26B | 179.47B | 167.63B | 129.30B | 115.47B | 116.17B | 106.11B | 103.03B | 101.25B | 96.69B | 88.65B | 84.19B | 77.05B | 66.26B | 54.02B | 47.21B | 39.58B | 34.21B | 27.52B | 19.25B | 11.78B | 12.50B | 12.03B |
| Gross Profit | 12.58B | 12.36B | 13.13B | 12.15B | 12.02B | 11.75B | 11.18B | 11.27B | 11.42B | 11.41B | 8.31B | 6.98B | 6.57B | 5.97B | 5.68B | 5.38B | 5.01B | 4.33B | 3.86B | 3.46B | 3.25B | 3.10B | 2.80B | 2.43B | 2.52B | 2.86B | 1.61B | 1.11B | 1.22B | 1.16B |
| Gross Profit Ratio | 4.07% | 4.47% | 4.97% | 5.10% | 5.20% | 5.48% | 5.37% | 5.68% | 5.98% | 6.37% | 6.04% | 5.70% | 5.35% | 5.33% | 5.22% | 5.04% | 4.93% | 4.66% | 4.39% | 4.30% | 4.67% | 5.43% | 5.59% | 5.79% | 6.87% | 9.43% | 7.71% | 8.61% | 8.88% | 8.82% |
| Research & Development | 179.00M | 89.00M | 70.00M | 74.00M | 96.00M | 71.00M | 125.00M | 341.00M | 392.00M | 392.00M | 456.00M | 480.00M | 440.00M | 407.00M | 376.00M | 364.00M | 347.00M | 284.00M | 223.00M | 182.00M | 172.70M | 149.40M | 135.10M | 147.50M | 112.60M | 114.70M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.91B | 15.55B | 21.07B | 17.70B | 18.34B | 8.40B | 8.14B | 7.47B | 7.28B | 7.90B | 5.42B | 2.35B | 3.07B | 2.76B | 2.57B | 3.08B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Selling & Marketing | 1.10B | -7.78B | -10.54B | -8.85B | -9.17B | -8.40B | -8.14B | -7.47B | -7.28B | -7.90B | -5.42B | 1.85B | 764.00M | 767.00M | 746.00M | 743.00M | 744.00M | 673.00M | 611.00M | 550.10M | 513.10M | 499.00M | 427.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.20B | 7.78B | 10.54B | 8.85B | 9.17B | 8.40B | 8.14B | 7.80B | 7.67B | 8.29B | 5.87B | 4.20B | 149.00M | 3.94B | 3.31B | 3.82B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Other Expenses | 298.00M | 497.00M | 259.00M | 223.00M | 12.00M | 182.00M | 130.00M | 90.00M | 58.00M | 63.00M | 32.00M | 10.00M | 3.21B | 2.98B | -20.00M | 3.08B | -5.00M | -6.00M | 45.00M | 1.20B | 0.00 | 0.00 | 22.00M | 111.60M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| Operating Expenses | 8.68B | 7.78B | 10.54B | 8.85B | 9.26B | 8.47B | 8.26B | 7.80B | 7.67B | 8.29B | 5.87B | 4.68B | 4.42B | 3.94B | 3.67B | 4.18B | 3.53B | 3.07B | 2.75B | 3.66B | 2.26B | 2.17B | 2.10B | 2.33B | 2.37B | 2.53B | 1.25B | 1.02B | 944.20M | 1.19B |
| Cost & Expenses | 305.04B | 272.13B | 261.37B | 234.93B | 228.29B | 211.04B | 205.44B | 195.06B | 187.14B | 175.93B | 135.17B | 120.15B | 120.59B | 110.05B | 106.69B | 105.44B | 100.23B | 91.71B | 86.94B | 80.71B | 68.52B | 56.19B | 49.31B | 41.91B | 36.58B | 30.05B | 20.50B | 12.79B | 13.44B | 13.22B |
| Interest Income | 118.00M | 107.00M | 10.00M | 12.00M | 49.00M | 39.00M | 48.00M | 29.00M | 18.00M | 20.00M | 23.00M | 22.00M | 19.00M | 18.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 283.00M | 308.00M | 353.00M | 374.00M | 303.00M | 240.00M | 251.00M | 222.00M | 187.00M | 144.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 635.00M | 857.00M | 1.00B | 1.22B | 922.00M | 949.00M | 951.00M | 910.00M | 885.00M | 1.02B | 704.00M | 591.00M | 551.00M | 496.00M | 474.00M | 441.00M | 371.00M | 295.00M | 266.00M | 250.90M | 232.10M | 203.70M | 207.50M | 246.10M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| EBITDA | 4.67B | 5.74B | 3.11B | -3.60B | 2.32B | 4.06B | 3.86B | 4.39B | 4.56B | 4.14B | 3.06B | 2.74B | 2.72B | 2.33B | 2.53B | 1.65B | 1.85B | 1.56B | 1.39B | 29.00M | 1.21B | 929.90M | 905.00M | 450.30M | 332.10M | 531.50M | 449.40M | 164.60M | 345.40M | 50.10M |
| EBITDA Ratio | 1.51% | 2.06% | 1.37% | 1.85% | 1.12% | 1.97% | 1.80% | 2.25% | 2.46% | 2.34% | 2.30% | 2.39% | 2.20% | 2.26% | 2.28% | 1.54% | 1.80% | 1.66% | 1.46% | 1.48% | 1.68% | 1.90% | 1.79% | 1.01% | 0.25% | 1.75% | 2.15% | 1.28% | 2.52% | 0.26% |
| Operating Income | 3.91B | 4.38B | 2.85B | 3.52B | 1.66B | 886.00M | 762.00M | 7.11B | 3.55B | 2.97B | 2.37B | 2.32B | 2.15B | 1.82B | 2.01B | 1.20B | 1.48B | 1.26B | 1.11B | -190.50M | 983.40M | 929.90M | 693.60M | 96.40M | 158.20M | 332.20M | 362.20M | 92.80M | 274.10M | -30.10M |
| Operating Income Ratio | 1.27% | 1.58% | 1.08% | 1.48% | 0.72% | 0.41% | 0.37% | 3.58% | 1.86% | 1.66% | 1.72% | 1.89% | 1.75% | 1.62% | 1.85% | 1.12% | 1.45% | 1.36% | 1.27% | -0.24% | 1.41% | 1.63% | 1.39% | 0.23% | 0.43% | 1.09% | 1.74% | 0.72% | 2.00% | -0.23% |
| Total Other Income/Expenses | -120.00M | 249.00M | -110.00M | 6.00M | -1.35B | -276.00M | -523.00M | -231.00M | -295.00M | -311.00M | -343.00M | -396.00M | -230.00M | -186.00M | -144.00M | -132.00M | -21.00M | 33.00M | 44.00M | -54.50M | -72.00M | -74.50M | -87.50M | -196.30M | 148.70M | -130.20M | -109.40M | -61.70M | -44.40M | -23.40M |
| Income Before Tax | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B | 3.25B | 2.66B | 2.10B | 1.92B | 1.92B | 1.64B | 1.86B | 1.06B | 1.46B | 1.30B | 1.16B | -239.80M | 911.40M | 855.40M | 601.20M | 9.60M | 306.90M | 202.00M | 253.50M | 36.40M | 224.10M | -81.70M |
| Income Before Tax Ratio | 1.23% | 1.67% | 0.73% | -2.11% | 0.50% | 0.28% | 0.11% | 3.47% | 1.70% | 1.48% | 1.52% | 1.57% | 1.56% | 1.46% | 1.71% | 1.00% | 1.43% | 1.39% | 1.32% | -0.30% | 1.31% | 1.50% | 1.20% | 0.02% | 0.84% | 0.66% | 1.22% | 0.28% | 1.63% | -0.62% |
| Income Tax Expense | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B | 908.00M | 815.00M | 742.00M | 581.00M | 516.00M | 505.00M | 601.00M | 241.00M | 468.00M | 329.00M | 421.00M | -83.10M | 264.90M | 293.30M | 182.60M | 52.30M | 122.30M | 117.10M | 98.60M | 31.30M | 88.70M | 111.50M |
| Net Income | 3.00B | 3.56B | 1.11B | -4.34B | 900.00M | 34.00M | 67.00M | 5.07B | 2.26B | 1.48B | 1.26B | 1.34B | 1.40B | 1.20B | 1.26B | 823.00M | 990.00M | 913.00M | 751.00M | -156.70M | 646.50M | 555.40M | 418.60M | -48.30M | 723.70M | 84.90M | 154.90M | 133.90M | 135.40M | 404.50M |
| Net Income Ratio | 0.97% | 1.29% | 0.42% | -1.82% | 0.39% | 0.02% | 0.03% | 2.55% | 1.18% | 0.82% | 0.92% | 1.09% | 1.14% | 1.07% | 1.16% | 0.77% | 0.97% | 0.98% | 0.85% | -0.19% | 0.93% | 0.97% | 0.84% | -0.11% | 1.97% | 0.28% | 0.74% | 1.04% | 0.99% | 3.07% |
| EPS | 22.54 | 25.23 | 7.31 | -27.02 | 4.97 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 | 5.71 | 5.70 | 4.65 | 4.70 | 2.99 | 3.40 | 3.06 | 2.46 | -0.53 | 2.23 | 1.92 | 1.47 | -0.17 | 2.57 | 0.31 | 1.14 | 0.83 | 1.53 | 4.60 |
| EPS Diluted | 22.39 | 25.04 | 7.23 | -27.02 | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 | 4.62 | 2.95 | 3.32 | 2.99 | 2.38 | -0.53 | 2.19 | 1.88 | 1.43 | -0.17 | 2.55 | 0.31 | 1.10 | 0.80 | 1.45 | 4.43 |
| Weighted Avg Shares Out | 133.20M | 141.10M | 152.30M | 160.60M | 181.00M | 196.30M | 208.00M | 221.00M | 230.00M | 232.00M | 229.00M | 235.00M | 246.00M | 258.00M | 269.00M | 275.00M | 291.00M | 298.00M | 306.00M | 294.00M | 290.00M | 289.30M | 285.20M | 283.10M | 281.30M | 275.20M | 282.10M | 83.65M | 88.50M | 87.93M |
| Weighted Avg Shares Out (Dil) | 134.10M | 142.20M | 154.10M | 160.60M | 182.00M | 197.30M | 209.00M | 223.00M | 233.00M | 235.00M | 233.00M | 239.00M | 251.00M | 263.00M | 273.00M | 279.00M | 298.00M | 305.00M | 316.00M | 294.00M | 299.00M | 298.80M | 298.10M | 283.10M | 284.20M | 275.20M | 282.10M | 84.39M | 93.38M | 91.31M |
Prediction: This Will Be the Best-Performing Stock in 2030
24/7 Wall St. Insights Selecting stocks for the long haul can be a challenge.
McKesson (MCK) Stock Dips While Market Gains: Key Facts
McKesson (MCK) reachead $488.78 at the closing of the latest trading day, reflecting a -1.95% change compared to its last close.
S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
At many points in September, investors heard about the S&P 500 hitting a record high. But at several points in that month, the index pulled back instead of moving higher.
Here's Why McKesson (MCK) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
You Should Be Investing in Dividend Growth Stocks. These Are the 2 Best to Buy In October
While dividend stock investing is one of the best strategies an investor can pursue to create phenomenal wealth, chasing yield can undermine the entire effort.
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Of The Day: Has McKesson Found Its Bottom And Will It Bounce Back?
The best traders traders focus on key price levels and stock momentum, understanding that oversold stocks at support often experience a rally.
McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2025 financial results after market close on Wednesday, November 6, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM...
4 Stocks to Buy Amid Dental Supplies Industry Challenges
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.
Source: https://incomestatements.info
Category: Stock Reports